Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. (Q48189013)

9 February 2018

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. (English)

1 reference

9 February 2018

0 references

Satoshi Hagiwara

1

1 reference

9 February 2018

Hideo Iwasaka

series ordinal

2

1 reference

9 February 2018

Takayuki Noguchi

series ordinal

3

1 reference

9 February 2018

publication date

30 May 2007

1 reference

9 February 2018

published in

Journal of Anesthesia

1 reference

9 February 2018

volume

21

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

164-170

1 reference

9 February 2018

Retraction Note to: Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.

is retracted by

0 references

cites work

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

HMGB1 as a late mediator of lethal systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Targeting complement in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Contributions of high mobility group box protein in experimental and clinical acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Extracellular role of HMGB1 in inflammation and sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Thrombin-induced intravascular coagulation: role in vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Role of the coagulation system in ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Coagulation, fibrinolysis, and fibrin deposition in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-006-0468-8

Acute respiratory distress syndrome

21 January 2018

1 reference

12 December 2020

Pancreatic proteases in serum induce leukocyte-endothelial adhesion and pancreatic microcirculatory failure

1 reference

12 December 2020

FUT-175 inhibits the production of IL-6 and IL-8 in human monocytes

1 reference

12 December 2020

Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats

1 reference

12 December 2020

Microthrombus formation enhances tumor necrosis factor-alpha production in the development of ischemia/reperfusion-induced liver injury in rats

1 reference

12 December 2020

The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS)

1 reference

12 December 2020

Comparative study on the in vitro effectiveness of antithrombotic agents

1 reference

12 December 2020

Effects of FUT-175, a new synthetic protease inhibitor on endotoxin-induced disseminated intravascular coagulation in rats

1 reference

12 December 2020

HMG-1 as a mediator of acute lung inflammation

1 reference

12 December 2020

Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.

1 reference

12 December 2020

The role of microvascular thrombosis in sepsis

1 reference

12 December 2020

Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats

1 reference

12 December 2020

Age-adjusted death rates: trend data based on the year 2000 standard population.

1 reference

12 December 2020

10.1007/S00540-006-0468-8

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

17458645

1 reference

9 February 2018